For the chemicals sector, it all depends on a transformation that is still unfolding and will take years to play out. Backward-integration ...

Rakesh Jhunjhunwala, the legendary “Big Bull” of Dalal Street, built his reputation through conviction and contrarian investing. A standout...

Prime Minister Modi unveiled a seven-pronged framework for India's developed nation status. This Saptadhara plan focuses on manufacturing, ...

Current government procurement policies can obstruct innovation, often favouring established firms. Furthermore, major Indian corporations ...

During the first quarter of fiscal 2027, India's pharmaceutical exports soared to $8.10 billion, showcasing remarkable strength in drug for...

India and the Southern African Customs Union signed terms to start trade negotiations. This move revives talks after previous rounds stalle...

Sustained market demand led to impressive revenue growth in the automotive and consumer goods sectors. In contrast, while the banking secto...

India and the SACU group will sign terms of reference for trade talks. Negotiations for a preferential trade agreement are expected to begi...

2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

Goldman Sachs expects the Nifty 50 to rebound to 26,500 by June 2027, above its current record high, as India’s macro backdrop improves. Lo...

To bolster India's medical device industry, a strategic pivot toward international markets and enhanced global presence is essential. Foste...

In 2025-26, India's ten largest import partner countries were China, UAE, Russia, US, Saudi Arabia, Iraq, Hong Kong, Switzerland, Singapore...

A new committee will monitor India's free trade agreements and export barriers. It must also address import efficiency for competitive glob...

India is planning a second phase for its production-linked incentive programme. This new phase will support high-performing sectors and red...

Exports from special economic zones experienced a remarkable boost in 2025-26, eclipsing USD 185 billion. The pharmaceutical industry also ...

India's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...